Table 4.
Changes of blood lipid levels in NAFLD model rats.
| Group | TG (mmol/L) | TC (mmol/L) | LDL-C(mmol/L) | HDL-C(mmol/L) |
|---|---|---|---|---|
| 4 weeks after HFD treatment | ||||
| Control | 1.94 ± 0.28 | 4.40 ± 0.87 | 0.83 ± 0.10 | 1.93 ± 0.35 |
| Model | 5.42 ± 0.65## | 6.03 ± 0.59## | 1.13 ± 0.30## | 1.65 ± 0.21# |
| Nuciferine | 5.37 ± 0.91## | 5.91 ± 0.94## | 1.16 ± 0.24## | 1.61 ± 0.26# |
| 12 weeks after HFD treatment | ||||
| Control | 1.92 ± 0.30 | 4.46 ± 1.26 | 0.85 ± 0.09 | 2.02 ± 0.56 |
| Model | 8.74 ± 2.04## | 7.60 ± 1.03## | 1.41 ± 0.25## | 1.49 ± 0.15# |
| Nuciferine | 4.22 ± 1.51** | 5.66 ± 1.51* | 0.93 ± 0.36* | 1.84 ± 0.37 |
Control, experimental model, and nuciferine-treated (n = 10 per group) groups. Data are presented as the mean ± SD. #p < 0.05 as compared to the control group; ##p < 0.01 as compared to the control group; *p < 0.05 as compared to the experimental model group; **p < 0.01 as compared to the experimental model group.